![]() |
Technical Data |
|
0004-02C |
4-1 BB Receptor, Recombinant, Human (4-1-BBR) |
5ug 20ug |
| Growth Factors, Cytokines | Storage: -20°CShipping: Blue Ice |
|
Recombinant Human soluble 4-1BB Receptor also called Tumor necrosis factor receptor superfamily member 9 produced in E. coli is a single, non-glycosylated polypeptide chain containing 167 amino acids, having a molecular mass of 17.718kD and containing the cysteine rich TNFR-like extracellular domain of recombinant 4-1BB Receptor. The human 4-1BB Receptor is purified by proprietary chromatographic techniques. Amino Acid Sequence: The sequence of the first five N-terminal amino acids was determined and was found to be Met-Glu-Arg-Thr-Arg. Dimers and Aggregates: 1% as determined by silver-stained SDS-PAGE gel analysis. Biological Activity: Recombinant 4-1BBr is fully biologically active when compared to standard. The activity was determined by the inhibition of 4-1BB ligand mediated stimulation of IL-8 production by human PBMC. Results: 90% inibition using 1µg for both human 4-1BB ligand and human 4-1BB receptor. Endotoxin: 0.1ng/ug (IEU/ug) of recombinant 4-1BBr. Solubility: It is recommended to reconstitute the lyophilized human 4-1BB Receptor in sterile 18M -cm H2O not less than 100ug/ml, which can then be further diluted to other aqueous solutions. Stability: Lyophilized recombinant human 4-1BB Receptor although stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution human 1-4BB Receptor should be stored at 4°C between 2-7 days and for future use below -180C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Please avoid freeze-thaw cycles. Molecular Weight: 17.72kD |
Source: E. coli Purity: 98% as determined by RP-HPLC, anion-exchange FPLC and/or reducing and non-reducing SDS-PAGE Silver Stained gel. Concentration: ~1mg/ml Form: Supplied as a lyophilized powder without additives. Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological. |
|
|
||